RLAY
Relay Therapeutics, Inc. · Healthcare
Chief Financial Officer Thomas Catinazzo sold $331K of Relay Therapeutics, Inc.
Sold$331,131
$18.69Price
17,717Shares
−10%Stake
What RLAY did after the filing
- The stock from Thu, Jul 9 open, $19.70
- −1.3%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 21 close.
Traded Mon, Jul 6. Filed Wed, Jul 8, 5:07 PM ET, after the close. Returns use the Jul 9 open and the Aug 21 close. Not investment advice.